Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) Post author: Post published:March 1, 2026 Post category: Continue ReadingDose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax Post author: Post published:March 1, 2026 Post category: Continue ReadingCirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS Post author: Post published:March 1, 2026 Post category: Continue ReadingCNS10-NPC-GDNF Delivered to the Motor Cortex for ALS
Continued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01 Post author: Post published:March 1, 2026 Post category: Continue ReadingContinued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingGuselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Post author: Post published:March 1, 2026 Post category: Continue ReadingStudy Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma